An empty reserve undermines national preparedness for health crises like pandemics and bioterrorism where rapid access to ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

By combining the ETHIC bill and a legislative formulation of a withdrawn USPTO rule, Congress has an opportunity to enact ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

The industry’s reputation surged during the COVID-19 pandemic, according to PatientView’s annual survey of patient groups, peaking two years ago, when 60% of those surveyed said pharma’s ...

Iraq's drug localization efforts save $1B annually, with 34 factories at full capacity & 178 new applications, says PM's advisor.